The reputation has been earned by repeated errors and a complete failure to generate value for shareholders.
The only winners have been board and execs on the gravy train.
Chuck 'em out and start again!!!
I know the clean out has started but leaving the CEO in place is a disaster given past form!!
DDD
- Forums
- ASX - By Stock
- MYX
- Ann: MAYNE PHARMA provides FDA update on generic NUVARING
MYX
mayne pharma group limited
Add to My Watchlist
1.00%
!
$5.05

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-31
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.05 |
Change
0.050(1.00%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$5.05 | $5.09 | $5.00 | $118.8K | 23.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 119 | $5.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.08 | 548 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 722 | 5.000 |
3 | 4948 | 4.990 |
2 | 923 | 4.980 |
3 | 1170 | 4.970 |
1 | 75 | 4.960 |
Price($) | Vol. | No. |
---|---|---|
5.030 | 2013 | 2 |
5.040 | 2513 | 4 |
5.050 | 125 | 1 |
5.060 | 985 | 3 |
5.070 | 125 | 1 |
Last trade - 10.24am 25/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |